Gene · 23408
Papers2,327
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,327
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Jianpi Huayu decoction suppresses hepatocellular carcinoma invasion and metastasis by inhibiting SIRT5-regulated Nrf2 activation and mitochondrial metabolic reprogramming. | Phytomedicine | 2026 | 42275883 | PubTator, text mining | PubMed |
| SIRT5-mediated FDX1 desuccinylation confers cuproptosis resistance in lung adenocarcinoma. | Cell Rep | 2026 | 42228571 | PubTator, text mining | PubMed |
| AKT1 glutarylation regulated by GCDH and SIRT5 suppresses oncogenic signaling. | Cell Rep | 2026 | 42207644 | PubTator, text mining | PubMed |
| SIRT5-dependent desuccinylation licenses UBR5-mediated degradation of TAMM41 to regulate mitochondrial metabolism in lung adenocarcinoma. | Biol Direct | 2026 | 42186063 | PubTator, text mining | PubMed |
| Succinylation in cancer immunotherapy: mechanisms, biomarkers, and therapeutic implications. | Front Immunol | 2026 | 42183207 | PubTator, text mining | PubMed |
| The Enigma of Protein Succinylation in Diabetes. | Curr Med Chem | 2026 | 42136307 | PubTator, text mining | PubMed |
| Tenuigenin regulates succinylation via SIRT5 for suppressing the tumorigenicity of hepatocellular carcinoma cells. | Front Pharmacol | 2026 | 42110557 | PubTator, text mining | PubMed |
| Thomas Willis Lecture Award: Nature's Blueprint for Ischemic Tolerance: Preconditioning and Postconditioning Strategies. | Stroke | 2026 | 42044228 | PubTator, text mining | PubMed |
| Elucidating binding hot spots and structural stability in sirtuin family proteins for selective inhibitors: a computational approach. | Front Bioinform | 2026 | 42038401 | PubTator, text mining | PubMed |
| SIRT5-RNF126 coordinated regulation of METTL17 stability controls mitochondrial function and glioma progression. | Cell Biosci | 2026 | 42021405 | PubTator, text mining | PubMed |
| Acetylation of GPRC5A at Lys348 facilitates cisplatin resistance and promotes the recurrence and poor prognosis in ovarian cancer. | Int J Biol Macromol | 2026 | 42009151 | PubTator, text mining | PubMed |
| Sechium edule var. nigrum spinosum (Chayote) Increases the mRNA Expression of Genes Encoding Sirtuins in Older Adults with Type 2 Diabetes Mellitus. | Molecules | 2026 | 41976223 | PubTator, text mining | PubMed |
| Succinylation modification in diabetes and diabetic complications: Mechanisms and functions (Review). | Mol Med Rep | 2026 | 41891977 | PubTator, text mining | PubMed |
| CLOCK-catalyzed histone H3K37 glutarylation suppresses H3K36 trimethylation pathways in glioblastoma. | Sci Adv | 2026 | 41880493 | PubTator, text mining | PubMed |
| ATP5A1 succinylation as a key driver for the transition of myocardial ischemia to development of heart failure. | Basic Res Cardiol | 2026 | 41879856 | PubTator, text mining | PubMed |
| The role and therapeutic potential of succinate and succinylation in cardiovascular diseases. | Clin Epigenetics | 2026 | 41872972 | PubTator, text mining | PubMed |
| Senescence as a Central Node in Alzheimer's Disease: Molecular Triggers, Cellular Effectors, and RNA-Based Interventions. | Neurochem Res | 2026 | 41870677 | PubTator, text mining | PubMed |
| Global molecular landscape of early MASLD progression in human obesity. | Elife | 2026 | 41870035 | PubTator, text mining | PubMed |
| STING-driven mitochondrial metabolism reverses cisplatin resistance via MDH2 desuccinylation in non-small cell lung cancer. | J Adv Res | 2026 | 41856470 | PubTator, text mining | PubMed |
| Mendelian Randomization Analyses Indicate a Causal Association Between Sodium-Glucose Cotransporter-1 Inhibition and Mitochondrial Function. | Curr Med Chem | 2026 | 41832709 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23408/papers?page=2